Harrow Health

Harrow Health, primarily operating through its ImprimisRx brand, maintains a strong reputation as a disruptive force in the ophthalmic pharmaceutical market. Customers, largely consisting of eye care professionals and their patients, appreciate the brand for its commitment to accessibility and affordability in a high-cost industry. Sentiment is generally positive, with many highlighting the clinical efficacy of their compounded formulations and the significant cost savings compared to traditional branded alternatives. While some users report occasional logistical complexities inherent to the compounding process, the prevailing view is one of trust and reliability. The brand is seen as a vital ally for those managing chronic eye conditions, offering innovative solutions that bridge the gap between expensive proprietary drugs and generic options. Overall, Harrow is respected for its patient-centric approach and its role in democratizing specialized eye care through high-quality, specialized medications.